The CDK9/2 inhibitor CYC065 that selectively targets MYCN-amplified neuroblastoma in vitro [37], caused growth arrest after 48 h and cell death in WT cultures upon prolonged treatment for 5 days. This evidence concerns the gene CDK9 and neuroblastoma.